BE in orodispersible tablets [Design Issues]

posted by ElMaestro  – Denmark, 2011-04-11 12:24 (5557 d 07:40 ago) – Posting: # 6885
Views: 4,496

Dear Dr_Dan,

page 22 of the holy scripture provides guidance.
Apart from blahblah the most important sentence in my opinion is "Bioequivalence studies should be conducted according to the recommended use of the product."

If the vols have never used such formulations before or are study-naïve they may be a bit nervous in the first period (or at least more nervous in the first than in the second). This may cause dry mouth in the first period but less so in the next etc, and can affect disperison time and thus add spurious variation. To minimise variation a bit of training therefore could be relevant.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
373 visitors (0 registered, 373 guests [including 17 identified bots]).
Forum time: 20:05 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5